Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0237 Transporter Info
Gene Name	SLC26A9
Transporter Name	Anion transporter/exchanger protein 9
Gene ID	115019
UniProt ID	Q7LBE3

Post-Translational Modification of This DT
Overview of SLC26A9 Modification Sites with Functional and Structural Information
Sequence	M S Q P R P R Y V V D R A A Y S L T L F D D E F E K K D R T Y P V G E K L R N A F R C S S A K I K A V V F G L L P V L S W L P K Y K I K D Y I I P D L L G G L S G G S I Q V P Q G M A F A L L A N L P A V N G L Y S S F F P L L T Y F F L G G V H Q M V P G T F A V I S I L V G N I C L Q L A P E S K F Q V F N N A T N E S Y V D T A A M E A E R L H V S A T L A C L T A I I Q M G L G F M Q F G F V A I Y L S E S F I R G F M T A A G L Q I L I S V L K Y I F G L T I P S Y T G P G S I V F T F I D I C K N L P H T N I A S L I F A L I S G A F L V L V K E L N A R Y M H K I R F P I P T E M I V V V V A T A I S G G C K M P K K Y H M Q I V G E I Q R G F P T P V S P V V S Q W K D M I G T A F S L A I V S Y V I N L A M G R T L A N K H G Y D V D S N Q E M I A L G C S N F F G S F F K I H V I C C A L S V T L A V D G A G G K S Q V A S L C V S L V V M I T M L V L G I Y L Y P L P K S V L G A L I A V N L K N S L K Q L T D P Y Y L W R K S K L D C C I W V V S F L S S F F L S L P Y G V A V G V A F S V L V V V F Q T Q F R N G Y A L A Q V M D T D I Y V N P K T Y N R A Q D I Q G I K I I T Y C S P L Y F A N S E I F R Q K V I A K T G M D P Q K V L L A K Q K Y L K K Q E K R R M R P T Q Q R R S L F M K T K T V S L Q E L Q Q D F E N A P P T D P N N N Q T P A N G T S V S Y I T F S P D S S S P A Q S E P P A S A E A P G E P S D M L A S V P P F V T F H T L I L D M S G V S F V D L M G I K A L A K L S S T Y G K I G V K V F L V N I H A Q V Y N D I S H G G V F E D G S L E C K H V F P S I H D A V L F A Q A N A R D V T P G H N F Q G A P G D A E L S L Y D S E E D I R S Y W D L E Q E M F G S M F H A E T L T A L
PTM type	X-O-glycosylation X-Phosphorylation X: Amino Acid

O-glycosylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC26A9			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	585
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC26A9 Serine 585 has the potential to affect its expression or activity.
Phosphorylation
Serine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC26A9			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	344
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A9 Serine 344 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC26A9			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	536
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A9 Serine 536 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC26A9			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	543
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A9 Serine 543 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC26A9			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	764
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A9 Serine 764 has the potential to affect its expression or activity.
Threonine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC26A9			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	336
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A9 Threonine 336 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC26A9			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	533
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A9 Threonine 533 has the potential to affect its expression or activity.
Tyrosine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC26A9			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	345
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A9 Tyrosine 345 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC26A9			[3]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	534
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A9 Tyrosine 534 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC26A9			[3]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	539
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A9 Tyrosine 539 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC26A9			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	762
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A9 Tyrosine 762 has the potential to affect its expression or activity.

References
1	Mapping and Quantification of Over 2000 O-linked Glycopeptides in Activated Human T Cells with Isotope-Targeted Glycoproteomics (Isotag). Mol Cell Proteomics. 2018 Apr;17(4):764-775.
2	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
3	Opposite Electron-Transfer Dissociation and Higher-Energy Collisional Dissociation Fragmentation Characteristics of Proteolytic K/R(X)n and (X)nK/R Peptides Provide Benefits for Peptide Sequencing in Proteomics and Phosphoproteomics. J Proteome Res. 2017 Feb 3;16(2):852-861.
4	Integrated analysis of global proteome, phosphoproteome, and glycoproteome enables complementary interpretation of disease-related protein networks. Sci Rep. 2015 Dec 11;5:18189.
5	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
6	Synthesizing Signaling Pathways from Temporal Phosphoproteomic Data. Cell Rep. 2018 Sep 25;24(13):3607-3618.
7	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
8	Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci Signal. 2010 Aug 24;3(136):ra64.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence